FLT3 and acute lymphoblastic leukemia: To direct cytotoxicity against Fms‐like tyrosine kinase (Flt3)‐positive B‐ALL cells, they built a CAR immunoglobulin‐like domain specific for Flt3, which led to enhanced antitumor activity.